Press Releases

Date Title and Summary View
Toggle Summary NxStage Kidney Care and Dialyze Direct to Provide On-Site Dialysis to Skilled Nursing Facility Patients in Ohio
LAWRENCE, Mass. , Aug. 11, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced that its NxStage Kidney Care subsidiary is partnering with Dialyze Direct, a leader in the area of geriatric dialysis and an
View HTML
Toggle Summary NxStage Reports Second Quarter Financial Results
- Company and Fresenius Medical Care Announce Definitive Agreement under which Fresenius Medical Care Will Acquire NxStage for $30.00 Per Share- Revenue Increases to $96.2 million, up 4% from Q2'FY16- Company Advances Pipeline with Launch of NxGen Hemodialysis System in NxStage Kidney Care
View HTML
Toggle Summary Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen Its Vertically Integrated Dialysis Business
Acquisition of NxStage Medical, Inc. would: position Fresenius Medical Care as a global leader in home dialysis establish U.S. presence in the critical care space further enhance clinical outcomes and patient empowerment support strategic initiative of vertical integration and Care Coordination
View HTML
Toggle Summary Over One Hundred NxStage Patients Celebrate Ten-Year Anniversary on Home Hemodialysis with the System One
LAWRENCE, Mass. , Aug. 4, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, joins over one hundred NxStage patients in celebrating their ten-year anniversary on home hemodialysis with the NxStage ® System One
View HTML
Toggle Summary NxStage® to Report Second Quarter 2017 Financial Results
LAWRENCE, Mass. , July 10, 2017 /PRNewswire/ --  NxStage Medical, Inc . (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today announced plans to release its financial results for the second quarter ended June 30, 2017 , on Wednesday, August 9, 2017 , before
View HTML
Toggle Summary NxStage Launches 3rd Annual Nurse Hero Contest to Celebrate Home Hemodialysis Nurses
LAWRENCE, Mass. , June 15, 2017 /PRNewswire/ -- NxStage Medical , Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care , today launched its 3 rd annual Nurse Hero contest to honor the critical role home hemodialysis nurses play in educating, training and
View HTML
Toggle Summary New Data from KIHDNEy Cohort Shows Improved Biochemical Outcomes and Broad Range Patient Suitability with More Frequent Hemodialysis Using the NxStage System One
Data presentations to be showcased at the 54th ERA-EDTA Congress
View HTML
Toggle Summary NxStage Announces Second Quarter 2017 Investor Conference Schedule
LAWRENCE, Mass. , May 25, 2017 /PRNewswire/ --  NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that Jeffrey H. Burbank , Chief Executive Officer, plans to participate in the following schedule of investor conferences.
View HTML
Toggle Summary NxStage Medical Announces FDA Clearance for its New System One Hemodialysis System
LAWRENCE, Mass. , May 10, 2017 /PRNewswire/ --  NxStage Medical, Inc . (NASDAQ: NXTM), a leading medical technology company focused on advancing renal care, today announced that its next generation hemodialysis system has received FDA clearance.  This innovative system consists of new features and
View HTML
Toggle Summary NxStage Reports First Quarter Financial Results
- Revenue Increases to $96.8 million, up 9% from Q1'FY16- Company Reaffirms Total Revenue Guidance and Profitability for 2017- Company Continues to Advance NxGen Hemodialysis System and Innovative Pipeline
View HTML